Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-Risankizumab Antibody (7G810)

😃Good
Catalog No. TMAS-00094
Alias Skyrizi, Risankizumab-rzaa, BI-655066, ABBV-066

Anti-Risankizumab Antibody (7G810) is a Rabbit antibody targeting Risankizumab. Anti-Risankizumab Antibody (7G810) can be used in ELISA, Sandwich ELISA, Competitive ELISA.

Anti-Risankizumab Antibody (7G810)

Anti-Risankizumab Antibody (7G810)

😃Good
Catalog No. TMAS-00094Alias Skyrizi, Risankizumab-rzaa, BI-655066, ABBV-066
Anti-Risankizumab Antibody (7G810) is a Rabbit antibody targeting Risankizumab. Anti-Risankizumab Antibody (7G810) can be used in ELISA, Sandwich ELISA, Competitive ELISA.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
40 μg$6097-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-Risankizumab Antibody (7G810) is a Rabbit antibody targeting Risankizumab. Anti-Risankizumab Antibody (7G810) can be used in ELISA, Sandwich ELISA, Competitive ELISA.
SynonymsSkyrizi, Risankizumab-rzaa, BI-655066, ABBV-066
Ig Type
IgG, κ
Clone
7G810
Specificity
Risankizumab
Application
Recommended Dose
ELISA: 0.01-1 µg/ml; Sandwich ELISA: 0.5-2 μg/ml; Competitive ELISA: 5-10 μg/ml
Antibody Type
Monoclonal
Host SpeciesRabbit
PurificationProtein A affinity column
AppearanceLyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
FormulationLyophilized with PBS, pH 7.2, containing 0.02% sodium azide.
Research BackgroundRisankizumab is a monoclonal antibody designed to target interleukin-23 (IL-23), a key cytokine involved in the inflammatory process of certain autoimmune diseases. By specifically binding to the p19 subunit of IL-23, Risankizumab inhibits its interaction with the IL-23 receptor, thereby reducing inflammation and immune responses. This mechanism makes Risankizumab particularly effective in the treatment of moderate to severe plaque psoriasis. The drug is marketed under the brand name Skyrizi and has shown superior efficacy compared to other biologics in its class. It is also being studied for potential use in other inflammatory conditions, such as Crohn's disease.
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Risankizumab
Chemical Properties
Stability & Storage
Stability & StorageThe lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-Risankizumab Antibody (7G810) | purchase Anti-Risankizumab Antibody (7G810) | Anti-Risankizumab Antibody (7G810) cost | order Anti-Risankizumab Antibody (7G810)